Screener
Apogee Therapeutics, Inc. APGE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development (1) | $60,819 | $46,387 |
| General and administrative | 21,953 | 16,709 |
| Total operating expenses | 82,772 | 63,096 |
| Loss from operations | (82,772) | (63,096) |
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s total operating expenses?
- Apogee Therapeutics, Inc. (APGE) reported total operating expenses of $82.77M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Apogee Therapeutics, Inc.'s total operating expenses increased by 31.2% year-over-year, from $63.1M to $82.77M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s total operating expenses has grown at a 75.2% compound annual growth rate (CAGR), from $93M to $285.6M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Apogee Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude